ABT-894

DRUG3 trials

Sponsors

Abbott, AbbVie (prior sponsor, Abbott)

Conditions

ADHDAttention-Deficit/Hyperactivity DisorderDiabetic NeuralgiaDiabetic Neuropathic PainDiabetic NeuropathiesDiabetic Neuropathy, PainfulDiabetic PolyneuropathyNeuralgia, Diabetic

Phase 2

A Dose-Ranging Study of the Efficacy of ABT-894 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)

CompletedNCT00429091

AbbottADHD, Attention-Deficit/Hyperactivity Disorder

Start: 2007-01-31Updated: 2010-11-02

Safety and Efficacy Study in Subjects With Diabetic Neuropathic Pain

CompletedNCT00507936

AbbVie (prior sponsor, Abbott)Diabetic Neuralgia, Diabetic Neuropathies, Diabetic Neuropathy, Painful +2

Start: 2007-08-31End: 2008-10-31Updated: 2013-01-23

A Safety and Efficacy Study in Subjects With Diabetic Neuropathic Pain

CompletedNCT00548925

AbbVie (prior sponsor, Abbott)Diabetic Neuropathic Pain

Start: 2007-11-30End: 2008-12-31Updated: 2013-01-21